Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(22):1719-1720; doi:10.1093/jnci/94.22.1719
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Milella, M.
Right arrow Articles by Nisticò, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milella, M.
Right arrow Articles by Nisticò, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 22, 1719-1720, November 20, 2002
© 2002 Oxford University Press

CORRESPONDENCE

Re: Mastectomy and Oophorectomy by Menstrual Cycle Phase in Women With Operable Breast Cancer

Michele Milella, Diana Giannarelli, Virginia Ferraresi, Marcella Mottolese, Claudio Botti, Cecilia Nisticò

M. Milella, V. Ferraresi (Division of Medical Oncology A), C. Nisticò (Division of Medical Oncology C), M. Mottolese (Division of Pathology), C. Botti (Division of Surgery A), and D. Giannarelli (Biostatistics Unit), Regina Elena National Cancer Institute, Rome, Italy.

Correspondence to: Michele Milella, M.D., Division of Medical Oncology A, Regina Elena, National Cancer Institute, Via Elio Chianesi n. 53, 00144 Rome, Italy (e-mail: milella@ifo.it).

The first 10% of the full text of this article appears below.

In their article recently published in the Journal, Love et al. (1) present provoking evidence that in a cohort of Vietnamese premenopausal breast cancer patients the timing of initiation of adjuvant hormone therapy (oophorectomy + tamoxifen) during the luteal phase of the menstrual cycle improves 5-year disease-free and overall survival. These data add fuel to the fire of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?